Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps ...

a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the ...

Tandem Diabetes Care shares ticked up after hours today on third-quarter results that topped the consensus forecast.

Tandem Diabetes Care (NASDAQ:TNDM – Free Report) had its target price boosted by Barclays from $58.00 to $60.00 in a research ...

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

This impressive performance was largely attributed to the successful launch of the company's Mobi insulin pump system. The Mobi launch has been a significant driver of growth for Tandem ...

The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ ...

Pump Shipments: Nearly 21,000 pumps in the US and nearly 11,000 pumps OUS. Tandem Diabetes Care Inc (NASDAQ:TNDM) achieved the highest quarterly sales in its history during Q3 2024, driven by ...

On Monday, Tandem Diabetes Care Inc (TNDM) stock saw a modest uptick, ending the day at $31.37 which represents a slight increase of $0.77 or 2.52% from the prior close of $30.6. The stock opened at ...

Tandem Diabetes Care reported a strong second quarter in 2024, outperforming expectations in both sales and EBITDA. This impressive performance was largely attributed to the successful launch of the ...

Tandem Diabetes Care Inc (TNDM) achieves highest quarterly sales in history, driven by strong US and international growth, ...